Clinical Trials Directory

Trials / Suspended

SuspendedNCT00181051

Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia

Status
Suspended
Phase
Phase 3
Study type
Interventional
Enrollment
128 (planned)
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Index computed in real time from Auditory Evoked Potentials have been described parallel to depth of anesthesia. The goal of the study was to compare general anesthesia guided on Auditory Evoked Potentials monitoring to standrad practice in order to assess if AEP monitoring can improve recovery delay (main criteria) or intraoperative hemodynamic stability (secondary criteria). Patients were randomized in 2 groups, stratified by center. Group I : AEP guided anesthesia, Group II: Blind AEP record, standard practice.

Conditions

Interventions

TypeNameDescription
DEVICEAlaris AEP monitor

Timeline

Start date
2003-02-01
First posted
2005-09-16
Last updated
2005-09-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT00181051. Inclusion in this directory is not an endorsement.